Group A (n = 41) | Group B (n = 61) | p value | |
---|---|---|---|
VAS | |||
Preoperative | 6.9 ± 1.7 (3–10) | 7.5 ± 1.9 (3–10) | 0.133 |
3 months follow-up | 3.1 ± 1.1 (0–5) | 2.6 ± 1.4 (0–5) | 0.031* |
6 months follow-up | 1.8 ± 1.2 (0–3) | 1.6 ± 1.4 (0–4) | 0.390 |
12 months follow-up | 1.6 ± 1.3 (0–4) | 1.4 ± 1.2 (0–3) | 0.342 |
24 months follow-up | 1.3 ± 1.1 (0–4) | 1.2 ± 1.1 (0–4) | 0.562 |
SSV | |||
Preoperative | 34.9 ± 15.7 (0–60) | 31.2 ± 16.1 (10–65) | 0.259 |
3 months follow-up | 53.7 ± 14.1 (30–90) | 60.8 ± 14.0 (40–90) | 0.013* |
6 months follow-up | 75.4 ± 13.5 (50–90) | 78.0 ± 11.1 (55–90) | 0.278 |
12 months follow-up | 83.8 ± 9.0 (50–95) | 85.9 ± 7.4 (65–95) | 0.198 |
24 months follow-up | 89.2 ± 13.8 (50–100) | 91.2 ± 12.6 (50–100) | 0.450 |
ASES score | |||
Preoperative | 35.4 ± 7.4 (16.7–55.0) | 36.7 ± 5.3 (30.0–60.0) | 0.307 |
3 months follow-up | 61.3 ± 16.4 (45.0–95.0) | 68.9 ± 15.7 (45.0–95.0) | 0.021* |
6 months follow-up | 87.8 ± 7.7 (70.0–100.0) | 89.5 ± 5.6 (75.0–100.0) | 0.213 |
12 months follow-up | 89.4 ± 4.0 (80.0–95.0) | 90.1 ± 5.1 (76.7–100.0) | 0.484 |
24 months follow-up | 88.0 ± 4.7 (71.7–96.7) | 90.0 ± 6.2 (71.7–100.0) | 0.157 |